First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer (Q64637968)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer |
clinical trial |
Statements
An Open-label, Phase I, Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY 2010112, Given Once Daily by Subcutaneous Administration or by Continuous Intravenous Infusion, in Subjects With Castration-resistant Prostate Cancer (English)
0 references
2 November 2012
0 references
18 July 2018
0 references
47
0 references
18 year
0 references